1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-6871.81%
Negative net income growth while CSIQ stands at 158.41%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
6.33%
D&A growth of 6.33% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
104.01%
Deferred tax of 104.01% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-2.63%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
77.62%
Well above CSIQ's 36.36% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-194.05%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
136.89%
Inventory growth of 136.89% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
8.02%
AP growth of 8.02% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
56.17%
Growth well above CSIQ's 36.36%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
1530.18%
Well above CSIQ's 126.30%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
39.38%
Operating cash flow growth below 50% of CSIQ's 171.37%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
47.70%
Some CapEx rise while CSIQ is negative at -1.91%. John Neff would see competitor possibly building capacity while we hold back expansions.
101.45%
Acquisition growth of 101.45% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-50.00%
Negative yoy purchasing while CSIQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
25166.86%
Liquidation growth of 25166.86% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
126.93%
Growth well above CSIQ's 33.39%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
137.35%
Investing outflow well above CSIQ's 4.41%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
83.67%
We have some buyback growth while CSIQ is negative at -13.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.